Acta Med. 1998, 41: 159-162

https://doi.org/10.14712/18059694.2019.182

Hyperprolactinemia in Obese as Well as in Lean Females of Koletsky Rats: Effect of Long Lasting Terguride Treatment

Věroslav Goldaa, Jana Jurčovičováb

aInstitute of Experimental Neurosurgery, Charles University, Faculty of Medicine and Teaching Hospital, Hradec Králové, Czech Republic
bInstitute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic

Received May 1, 1998
Accepted October 1, 1998

References

1. Cincotta AH, Meier AH. Reduction of body fat stores by inhibition of prolactin secretion. Experientia 1987; 43:416-7. <https://doi.org/10.1007/BF01940433>
2. Golda V, Cvak L. Terguride but not bromocriptine alleviated glucose tolerance abnormalities and hyperlipidemia in obese and lean genetically hypertensive Koletsky rats. Physiol Res 1994; 43:299-305.
3. Koletsky S. Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 1975; 80:119-40.
4. Meier AH, Cincotta AH, Lowell WC. Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycaemia in type II diabetes. Experientia 1992; 48:248-53. <https://doi.org/10.1007/BF01930467>
5. Schernthaner G, Prager R, Punzengruber C, Luger A. Severe hyperprolactinemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia 1985; 28:138-42.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive